Wiskott-Aldrich Syndrome: a cytoskeleton disease

Similar documents
The Wiskott-Aldrich syndrome: An Immunodeficiency due to a defective cytoskeleton

Wiskott-Aldrich Registry Data Collection Form Patient Identification: Patient Name (first, middle, last)

Primary Immunodeficiency

The Wiskott-Aldrich syndrome CLINICAL AND PATHOLOGIC MANIFESTATIONS

WISKOTT-ALDRICH SYNDROME. An X-linked Primary Immunodeficiency

Form 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data

Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and Treatment

Wiskott Aldrich syndrome with bronchiectasis $

Chapter 11. B cell generation, Activation, and Differentiation. Pro-B cells. - B cells mature in the bone marrow.

Problem 7 Unit 6 Clinical: Primary immunodeficiency

Chapter 11. B cell generation, Activation, and Differentiation. Pro-B cells. - B cells mature in the bone marrow.

Is it CVID? Not Necessarily HAIG TCHEUREKDJIAN, MD

Defensive mechanisms include :

WIP: more than a WASp-interacting protein

Immunobiology 7. The Humoral Immune Response

Autoimmunity and Primary Immune Deficiency

Actin cytoskeletal defects in immunodeficiency

HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist.

Effector T Cells and

Immunodeficiency. By Dr. Gouse Mohiddin Shaik

Atopic Dermatitis and Primary Immunodeficiency: When Should I Worry?

Immunological Aspects of Parasitic Diseases in Immunocompromised Individuals. Taniawati Supali. Department of Parasitology

Immune Reconstitution Following Hematopoietic Cell Transplant

T Cell Effector Mechanisms I: B cell Help & DTH

Immunology Lecture 4. Clinical Relevance of the Immune System

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Innate vs Adaptive Response

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

One Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases

Introduction to Immune System

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Central tolerance. Mechanisms of Immune Tolerance. Regulation of the T cell response

Mechanisms of Immune Tolerance

Immunological alterations in mice irradiated with low doses

Immunodeficiency. (1 of 2)

Adaptive Immunity. Jeffrey K. Actor, Ph.D. MSB 2.214,

S. No Topic Class No Date

Immunology and the middle ear Andrew Riordan

M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

The Immune System. A macrophage. ! Functions of the Immune System. ! Types of Immune Responses. ! Organization of the Immune System

Immunosuppressants. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Primer on Tumor Immunology. International Society for Biological Therapy of Cancer. C. H. June, M.D. November 10, 2005

Adaptive immune responses: T cell-mediated immunity

Immune system. Self/non-self recognition. Memory. The state of protection from infectious disease. Acceptance vs rejection

Examples of questions for Cellular Immunology/Cellular Biology and Immunology

Development of B and T lymphocytes

There are 2 major lines of defense: Non-specific (Innate Immunity) and. Specific. (Adaptive Immunity) Photo of macrophage cell

Case Presentations in Primary Immune Deficiency Diseases. John W. Sleasman, M.D. St Petersburg, FL Mark Ballow, M.D. Buffalo NY & Sarasota, FL

Attribution: University of Michigan Medical School, Department of Microbiology and Immunology

The Adaptive Immune Responses

Immunology. Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Cytokines modulate the functional activities of individual cells and tissues both under normal and pathologic conditions Interleukins,

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009

The Adaptive Immune Response. B-cells

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

1. Overview of Adaptive Immunity

The incidence of the classic Wiskott-Aldrich syndrome

The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function

Principles of Adaptive Immunity

Chapter 11. Hyper IgM Syndromes

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas

Physiology Unit 3. ADAPTIVE IMMUNITY The Specific Immune Response

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP

Hematopoiesis. Hematopoiesis. Hematopoiesis

regulation of polarized membrane transport by rab GTPases Peter van der Sluijs;

T cell maturation. T-cell Maturation. What allows T cell maturation?

Darwinian selection and Newtonian physics wrapped up in systems biology

Immunodeficiencies and Genetic Mutations Affecting NK Cells in Humans Prof. Jordan Orange MD/PhD

Biology of Immune Aging

Chapter 19: IgE-Dependent Immune Responses and Allergic Disease

Acute Immune Thrombocytopenic Purpura (ITP) in Childhood

IMMU 7630 Fall 2011 IMMUNODEFICIENCY

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

Dr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION

Cytokines (II) Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School

From the Diagnostic Immunology Laboratories

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Mon, Wed, Fri 11:00 AM-12:00 PM. Owen, Judy, Jenni Punt, and Sharon Stranford Kuby-Immunology, 7th. Edition. W.H. Freeman and Co., New York.

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Basis and Clinical Applications of Interferon

Immunology for the Rheumatologist

LESSON 2: THE ADAPTIVE IMMUNITY

Basis of Immunology and

Chapter 24 The Immune System

T Cell Activation, Costimulation and Regulation

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

I. Defense Mechanisms Chapter 15

Lecture 4. T lymphocytes

Transcription:

Wiskott-Aldrich Syndrome: a cytoskeleton disease Elie Haddad, MD, PhD Pediatric Immunology and Rheumatology CHU Ste-Justine Université de Montréal, Montreal, QC, Canada

Wiskott-Aldrich Syndrome A disease of the hematopietic and immune system X-linked Involving platelets and lymphocytes Responsible of the classical clinical triad : Thrombopenia Immune deficiency Eczema

Platelet abnormalities Constant (100%) and very early finding Thrombopenia Small volume platelets (3.8 to 5 fl) half that of healthy controls From non-life threatening (epistaxis, petechiae, purpura, oral bleeding) to severe manifestations such as intestinal and intracranial bleeding. Death of WAS patients is caused, in 21% of the cases, by haemorrhages

Immune deficiency (Clinical aspects) Progressive Infections Mainly pyogenic Also viral, fungal and opportunistic Auto-immunity Up to 72% of patients Autoimmune hemolytic anemia Vasculitis Neutropenia IBD Renal disease (IgA or HSP like nephropathy) Malignancy (mainly B-cell lymphoma, poor prognosis)

Immune deficiency (biological aspects) Hypo IgM, Hyper IgA-E, normal IgG Impaired antibody response to T-independent antigen (bacterial polysaccharidic Ag), and sometimes to T-dependent protein antigens Progressive T-cell lymphopenia Reduced in vitro T proliferation in response to mitogens, allogenic stimulation and immobilized anti-cd3 mab Difference between XLT et WAS

WAS-XLT scoring system XLT WAS Clinical scores 0.5 1 2 3 4 5A 5B Thrombocytopenia +/- + + + + + + Eczema - - +/- + ++ ++/- ++/- Immuodeficiency - - +/- + ++ ++/- ++/- Autoimmunity - - - - - + - Malignancy - - - - - - + The phenotype may evolve over time and is often incomplete in < 2 years old patients. Progression of the disease is also possible at later age Scoring system according to Zhu et al Blood 1997 and Imai et al Curr Opin Allergy Clin Immunol 2003

The gene and the protein Gene codes for the WASP protein, 502 AA ARNm : exclusively in hematopoïetic cells WASP is involved in the cytoskeleton regulation WAS and XLT result from «loss-of-function» mutations of WAS gene I will not speak of X-linked neuropenia due to gain of function WASP mutation

Structure of WASP SH3 Cdc42-GTP Rac-GTP Adapter proteins: Nck, Grb2, Tyrosine kinases: Fyn, Btk, VCA Cofilin homology domain N WH1/PH B CRIB Y Poly-Pro WH2/VH CH P Fyn WASP-homology domain 2 or Verproline Homology domain C Phosphatase Actine Arp2/3 Functions of WASp dowstream of TCR, including actin polymerisation and IS formation in vitro Actin polymerization

STIMULATION Toca-1 Cdc42 GDP N Cdc42 GTP C CH VH B CRIB Inactive auto-inhibited WASP Cdc42 GTP N B CRIB Active WASP Polymerization VH CH C Arp2/3 Actin

Structure of WASP PiP2 SH3 Cdc42-GTP Rac-GTP Adapter proteins: Nck, Grb2, Tyrosine kinases: Fyn, Btk, VCA N WH1/PH WIP Recruitment of WASP to the Immune Synapse Protects WASP from degradation? Role in the stabilization of auto-inhibited conformation? B CRIB Y Poly-Pro WH2/VH CH P Phosphatase Fyn Filopodia, Cell polarization, Chemotaxis WASP-homology domain 2 or Verproline Homology domain Actine Actin polymerization Cofilin homology domain Arp2/3 C

Role of WASP Transduction of signals from the surface to the actin cytoskeleton Role in actin polymerization, cell polarization Essential functions: Cell locomotion, cell trafficking Intracellular signaling Immune synapse formation and organization Cell-cell interaction Cytotoxicity All functions important for adaptive and innate immunity and immune surveillance

Minor role of WASP in early hematopoietic cell development Significant growth and/or survival disadvantage of mature WASP deficient cells Thrasher et al, Nat Rev Immunol 2010

T-cell dysfunction Progressive T-cell lymphopenia by decreased thymic output and decreased peripheral T cell survival Abnormal T cell morphology Role in the formation of the IS between APC and T-cell lower levels of lipid raft Downstream of T-cell receptor ligation at the IS: Defective actin polymerization Failure to recruit proteins Abnormal proliferative response, defective calcium influx Decreased production of IL-2 and TH1 cytokine (then unbalanced Th2 response) Failure to polarize cytokine secretion toward antigen-specific target cells

T-reg dysfunction WASP-deficient T-reg cells fail to proliferate normally in response to TCR stimulation and their suppressive activity is impaired in vitro Role of T-reg cells in the autoimmunity of mice WAS models is clear Less clear in humans: Number of peripheral T-reg cells are normal Maybe an intrinsic cellular dysfunction

NK and inkt cell dysfunction NK cells: Normal or increased NK cell numbers Impaired NK-cell cytotoxicity, and NK cell migration inkt cells inkt absent in WAS and normal/decreased in XLT WASP is important for inkt homeostasis and function, and also for late-stage thymus development and egress Suggested role of inkt cells in clearance of microorganisms, tumour surveillance and protection from autoimmunity

DC and macrophage/pn dysfunction Human WASP-deficient myeloid lineage cells exhibit impaired phagocytosis monocytes, macrophages, DCs and osteoclasts show almost completely abrogated assembly of podosomes Impaired migration and homing of Macrophages and DC Mobility defect of DC confirmed in vivo Defects in cell-to-cell interactions: abnormal DC-mediated induction of immune synapse formation in T cells

B-cell dysfunction Clinically, clear defect in humoral immunity but until recently, role of WASP in B cells not deeply studied Impaired adhesion, migration and homing Abnormal B cell homeostasis with selective depletion of circulating mature B cells, splenic marginal zone precursors and marginal zone B cells Reduced expression of CD21 and CD35 Intrinsic B-cell defect, not corrected by normal T cells in chimerism situation, likely responsible for humoral immune deficiency and some autoimmunity

Mechanism of thrombopenia? Profound microthrombocypenia is the hallmark of the disease Risk of life-threatening hemorraghea without clear correlation with the intensity of thrombopenia: risk difficult to manage Mechanism still uncompletely understood, likely central and peripheral mechanisms Both an immune-mediated mechanism and intrinsic platelet abnormalities There is also defective function of platelets responsible for bleeding risk

Mechanism of autoimmunity? Role of Treg: abnormal homeostasis and function Role of B cells that intrinsicallly secrete auto-antibodies High frequency of autoimmunity post transplant, associated with mixed chimerism Chimeric mouse model of WASP-/- B cells with WASP + other lineages: increased autoimmunity

Thrasher et al, Nat Rev Immunol 2010

Diagnosis: key words Male Microthrombocytopenia Progressive immune deficiency WASP sequencing

Patient L.N. Uncle, same mutation L.N. s brother, ITP, no mutation ITP in a girl

Management of WAS patients Supportive therapy: Treatment of thrombopenia : somewhat similar to ITP, but more difficult IVIG/ScIG, Bactrim prophylaxis Immunosuppression for autoimmune manifestations Targeted anti-microorganism therapy Bone marrow transplantation HLA id sibling, MUD and matched CB: overall good results Better to obtain a good stable chimerism > 5 years: poorer outcome for MUD but still 73% survival Splenectomy associated with a poorer outcome WAS = indication of HSCT (Moratto et al Blood 2011, Oszahin et al Blood 2008, Filipovich et al Blood 2001 )

Management of WAS patients (2) Gene therapy Surely a good option in next future for patients without a «good» donor To be confirmed: maybe larger indications or maybe not a so good strategy

Conclusions Mutations of WASP are associated with a remarkably wide and variable clinical spectrum Studying the mechanisms of WAS led to a better understanding of the role of the cytoskeleton in the function and homeostasis of the immune system Clinical retrospective studies on XLT and HSCT for WASP have led to a better clinical strategy Some decisions are still very difficult and controversial I recommand: Albert et al Curr Op Hematol 2011, Thrasher et al Nat rev Immunol 2010, Albert et al Blood 2010, Moratto et al Blood 2011